» Articles » PMID: 27848219

The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review

Overview
Specialty Pharmacology
Date 2016 Nov 17
PMID 27848219
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is a growing interest in incorporating informal care in cost-of-illness studies as a relevant part of the economic impact of some diseases.

Objective: The aim of this paper was to review the recent literature valuating the costs of informal care in a group of selected diseases from 2005 to 2015.

Methods: We carried out a systematic review on the economic impact of informal care, focusing on six selected diseases: arthritis or osteoarthritis, cancer, dementia, mental diseases, multiple sclerosis and stroke.

Results: We selected 91 cost-of-illness articles. The average weight attributed to the informal care cost over the total cost was highly relevant for dementia, stroke, mental diseases, cancer and multiple sclerosis. The most frequent valuation method applied was the opportunity cost method, followed by the proxy good method. The annual cost of informal care presented a high variability depending on the disease and geographic location. Distinguishing by type of illness, the disease with the highest annual value of informal caregiving was dementia, followed by mental illness and multiple sclerosis. The average hourly unit cost was €11.43 (2015 values), varying noticeably depending on the geographic location.

Conclusion: This paper identifies several aspects that should be enhanced to promote comparability between studies and countries, and it sends key messages for incorporating informal care costs to adequately measure the economic impact of diseases.

Citing Articles

Regional health priorities for dementia: a roadmap for the Western Pacific.

Timmins H, Mok V, Kim S, Shahrizaila N, Sung J, Sobue G Lancet Reg Health West Pac. 2024; 50:101179.

PMID: 39399866 PMC: 11471056. DOI: 10.1016/j.lanwpc.2024.101179.


Time value of informal care of people with alzheimer's disease in Spain: a population-based analysis.

C V, J O Eur J Health Econ. 2024; .

PMID: 39117786 DOI: 10.1007/s10198-024-01713-y.


Social costs associated with fibromyalgia in Spain.

Oliva-Moreno J, Vilaplana-Prieto C Health Econ Rev. 2024; 14(1):51.

PMID: 38997577 PMC: 11245780. DOI: 10.1186/s13561-024-00527-1.


Economic impact of informal caring for a person with arthritis in Australia from 2015 to 2030: a microsimulation approach using national survey data.

Schofield D, Lim K, Tanton R, Veerman L, Kelly S, Passey M BMJ Open. 2024; 14(5):e076966.

PMID: 38719327 PMC: 11086496. DOI: 10.1136/bmjopen-2023-076966.


Profile and burden of the family caregiver: the caring experience in multiple sclerosis. An observational study.

Ponzio M, Tacchino A, Verri A, Battaglia M, Brichetto G, Podda J BMC Psychol. 2024; 12(1):173.

PMID: 38528601 PMC: 10964650. DOI: 10.1186/s40359-024-01678-w.


References
1.
Neubauer S, Holle R, Menn P, Grossfeld-Schmitz M, Graesel E . Measurement of informal care time in a study of patients with dementia. Int Psychogeriatr. 2008; 20(6):1160-76. DOI: 10.1017/S1041610208007564. View

2.
Koopmanschap M, van Ineveld B . Towards a new approach for estimating indirect costs of disease. Soc Sci Med. 1992; 34(9):1005-10. DOI: 10.1016/0277-9536(92)90131-9. View

3.
Hoefman R, van Exel J, Brouwer W . How to include informal care in economic evaluations. Pharmacoeconomics. 2013; 31(12):1105-19. DOI: 10.1007/s40273-013-0104-z. View

4.
Oliva-Moreno J, Pena-Longobardo L, Vilaplana-Prieto C . An estimation of the value of informal care provided to dependent people in Spain. Appl Health Econ Health Policy. 2015; 13(2):223-31. DOI: 10.1007/s40258-015-0161-x. View

5.
Chari A, Engberg J, Ray K, Mehrotra A . The opportunity costs of informal elder-care in the United States: new estimates from the American Time Use Survey. Health Serv Res. 2014; 50(3):871-82. PMC: 4450934. DOI: 10.1111/1475-6773.12238. View